Insider Transactions Reported by 12 Insiders of Gain Therapeutics, Inc.

Symbol
GANX on Nasdaq
Location
Bethesda, MD

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Gain Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric I. Richman Director $1,174,903 24 Jun 2025
Khalid Islam Director $929,667 24 Jun 2025
Charles Evan Ballantyne Chief Financial Officer $125,000 10 Apr 2023
Matthias Alder Chief Executive Officer, Director $110,433 26 Mar 2024
Salvatore Calabrese Chief Financial Officer $62,500 23 Mar 2023
Gene Mack CEO, President, Director $14,544 20 Mar 2025
Gwen A. Melincoff Director 24 Jun 2025
Jeffrey Scott Riley Director 24 Jun 2025
DOV A. GOLDSTEIN MD Director 24 Jun 2025
Claude Nicaise Director 24 Jun 2025
HANS PETER HASLER Director 24 Jun 2025
Gianluca Fuggetta Principal Accounting and Financial Officer 20 Mar 2025

Recent Insider Transactions by Companies or Individuals for Gain Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Khalid Islam GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Claude Nicaise GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Jeffrey Scott Riley GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Eric I. Richman GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Hans Peter Hasler GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
DOV A. GOLDSTEIN MD GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Gwen A. Melincoff GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2025 Direct
Gianluca Fuggetta GANX Employee Stock Option (right to buy) Award 50,000 50,000 20 Mar 2025 Direct
Gene Mack GANX Employee Stock Option (right to buy) Award 200,000 200,000 20 Mar 2025 Direct
Gene Mack GANX Stock Option (right to buy) Award 271,325 271,325 06 Jan 2025 Direct
Gene Mack GANX Common Stock Purchase $14,544 $1.01 14,400 14,400 09 Aug 2024 Direct
Khalid Islam GANX Common Stock Purchase $49,940 $0.9988 50,000 50,000 09 Aug 2024 Direct
ERIC I. RICHMAN GANX Common Stock Purchase 6.24% 17,000 289,629 01 Jul 2024 Direct
Khalid Islam GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
Gwen A. Melincoff GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
HANS PETER HASLER GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
Claude Nicaise GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
DOV A. GOLDSTEIN MD GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
ERIC I. RICHMAN GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
Jeffrey Scott Riley GANX Stock Option (right to buy) Award 15,000 15,000 24 Jun 2024 Direct
Gene Mack GANX Employee Stock Option (right to buy) Award 200,000 200,000 08 Apr 2024 Direct
Jeffrey Scott Riley GANX Common Stock Purchase $115,770 $3.86 30,000 30,000 28 Mar 2024 Direct
Matthias Alder GANX Common Stock Tax liability -22.4% -6,085 21,140 26 Mar 2024 Direct
Matthias Alder GANX Common Stock Options Exercise 288.2% 20,212 27,225 26 Mar 2024 Direct
Matthias Alder GANX Restricted Stock Units Options Exercise -76% -20,212 6,376 26 Mar 2024 Direct
Gianluca Fuggetta GANX Employee Stock Option (right to buy) Award 50,000 50,000 21 Mar 2024 Direct
Matthias Alder GANX Employee Stock Option (right to buy) Award 370,000 370,000 21 Mar 2024 Direct
Matthias Alder GANX Common Stock Sale -3.75% $507 $2.46 -206 5,286 21 Dec 2023 Direct
Matthias Alder GANX Common Stock Options Exercise 13.1% 637 5,492 20 Dec 2023 Direct
Matthias Alder GANX Restricted Stock Units Options Exercise -8.33% -637 7,013 20 Dec 2023 Direct
Matthias Alder GANX Common Stock Sale -27.3% $4,550 $2.50 -1,820 4,855 07 Dec 2023 Direct
Matthias Alder GANX Common Stock Options Exercise 14.1% 825 6,675 01 Oct 2023 Direct
Matthias Alder GANX Restricted Stock Units Options Exercise -8.33% -825 9,075 01 Oct 2023 Direct
Matthias Alder GANX Common Stock Options Exercise 77.3% 2,550 5,850 20 Sep 2023 Direct
Matthias Alder GANX Restricted Stock Units Options Exercise -25% -2,550 7,650 20 Sep 2023 Direct
ERIC I. RICHMAN GANX Common Stock Options Exercise 25.2% 54,900 272,629 20 Sep 2023 Direct
ERIC I. RICHMAN GANX Restricted Stock Units Options Exercise -100% -54,900 0 20 Sep 2023 Direct
Matthias Alder GANX Common Stock Options Exercise 3,300 3,300 01 Jul 2023 Direct
Matthias Alder GANX Restricted Stock Units Options Exercise -25% -3,300 9,900 01 Jul 2023 Direct
Khalid Islam GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
Claude Nicaise GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
Gwen A. Melincoff GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
Jeffrey Scott Riley GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
HANS PETER HASLER GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
DOV A. GOLDSTEIN MD GANX Stock Option (right to buy) Award 10,500 10,500 23 Jun 2023 Direct
Charles Evan Ballantyne GANX Restricted Stock Units Award 50,000 50,000 10 Apr 2023 Direct
Charles Evan Ballantyne GANX Employee Stock Option (right to buy) Award 100,000 100,000 10 Apr 2023 Direct
Salvatore Calabrese GANX Restricted Stock Units Award 25,000 25,000 23 Mar 2023 Direct
Salvatore Calabrese GANX Employee Stock Option (right to buy) Award 50,000 50,000 23 Mar 2023 Direct
Gianluca Fuggetta GANX Employee Stock Option (right to buy) Award 15,000 15,000 23 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.